Although some may say not recruiting yet, they are in the process.
The first is called the NEMO trial by Novartis, it is for NRAS positive folks only.
It is a randomized phase III trial with their Mek inhibitor. Look it up at Clinicaltrials.gov by: NCT01763164.
The second is the Columbus Trial, again Novartis. It features their BRAF inhibitor: NCT01909453
If you have any questions please let me know here or by emailing me: cpoole@melanomainternational.org